Is Gilead Sciences a Good Coronavirus Stock?
In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Brian Orelli discuss the drugmakers that have developed treatments for COVID-19, the disease caused by the novel coronavirus. Orelli points to Gilead Sciences (NASDAQ: GILD), which has gained an emergency use authorization from the Food and Drug Administration for its antiviral remdesivir. But he stresses that investors should look at the biotech's entire portfolio of drugs and where future growth will come from.
Source Fool.com
